ストックスクリーナーアプリを入手
210.91
3.56%
7.26
前日終値:
$203.65
開ける：
$204.87
24時間の取引高:
1.87M
Relative Volume:
2.67
時価総額：
$15.30B
収益：
$2.88B
当期純損益:
$499.60M
株価収益率:
31.29
EPS:
6.74
ネットキャッシュフロー:
$321.60M
1週間 パフォーマンス:
-1.78%
1か月 パフォーマンス:
-38.81%
6か月 パフォーマンス:
-30.69%
1年 パフォーマンス:
-40.79%
1日の値動き範囲:
$204.37
$212.98
1週間の範囲:
$201.25
$216.98
52週間の値動き範囲:
$197.01
$400.88
West Pharmaceutical Services Inc Stock (WST) Company Profile
名前
West Pharmaceutical Services Inc
セクター
電話
(610) 594-2900
住所
530 HERMAN O. WEST DRIVE, EXTON, PA
WST を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
210.91 | 15.30B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 開始されました | Citigroup | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-12 | アップグレード | UBS | Neutral → Buy |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-11 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-11-30 | 開始されました | UBS | Neutral |
| 2022-10-28 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 開始されました | Stephens | Equal-Weight |
| 2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-04-24 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | ダウングレード | Jefferies | Buy → Hold |
| 2019-04-23 | 開始されました | William Blair | Outperform |
| 2018-04-25 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2017-10-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 開始されました | Stephens | Equal-Weight |
| 2017-09-15 | アップグレード | Jefferies | Hold → Buy |
| 2016-10-28 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 開始されました | Wells Fargo | Outperform |
| 2010-05-14 | 繰り返されました | UBS | Neutral |
| 2010-02-23 | 開始されました | Jefferies & Co | Buy |
| 2008-12-19 | 開始されました | UBS | Neutral |
すべてを表示
West Pharmaceutical Services Inc (WST) 最新ニュース
Top 2 Health Care Stocks That May Rocket Higher This Month - Benzinga
West Pharmaceutical sets Q2 dividend at $0.21 per share By Investing.com - Investing.com Australia
Insider Decision Unfolding At West Pharmaceutical Servs: Eric Green Exercises Options, Resulting In $0 - Benzinga
Chad Winters Decides To Exercise Options At West Pharmaceutical Servs Worth $0 - Benzinga
Options Exercise Update At West Pharmaceutical Servs: Kimberly MacKay Engages, Resulting In $0 - Benzinga
Engaging In Insider Activity, Cindy Reiss-Clark At West Pharmaceutical Servs Exercises Options Worth $0 - Benzinga
West Pharmaceutical Services, Inc. Announces Second Quarter 2025 Dividend, Payable on May 7, 2025 - Marketscreener.com
West Announces Second-Quarter Dividend - The Malaysian Reserve
West Pharmaceutical sets Q2 dividend at $0.21 per share - Investing.com
Jefferies Adjusts West Pharmaceutical Services Price Target to $240 From $393, Maintains Buy Rating - Marketscreener.com
WEST PHARMACEUTICAL SERVICES INC SEC 10-K Report - TradingView
Wall Street Bounces Back: Top-Performing ETFs Of Last Week - Benzinga
Why Did West Pharmaceutical Services Stock Drop Almost 40%? - Nasdaq
Why West Pharmaceutical Services (WST) Crashed Last Week? - MSN
West Pharmaceutical Services Reports Strong Q4, Introduces 2025 Financial Guidance - MSN
WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down - MSN
West Pharmaceuticals Takes A Plunge, But May Still Offer Opportunities (NYSE:WST) - Seeking Alpha
West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin - MSN
Reddit, GoDaddy & Trade Desk Are Among Top 11 Large-Cap Losers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? - Benzinga
West Pharmaceutical Services, Inc. (NYSE:WST) Just Reported, And Analysts Assigned A US$306 Price Target - Yahoo Finance UK
West Pharma upgraded at Deutsche Bank despite earnings led selloff - MSN
West Pharma's 2025 Forecast Misses Estimates as Inventory Reductions Continue - Medical Dialogues
Why West Pharmaceutical Services, Inc. (WST) Went Down on Thursday - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) Stock Position Raised by Van ECK Associates Corp - MarketBeat
Consolidated Planning Corp Buys 2,051 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharma stock falls as 2025 guidance disappoints - MSN
KeyCorp Has Lowered Expectations for West Pharmaceutical Services (NYSE:WST) Stock Price - MarketBeat
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN
West Pharmaceutical Services (NYSE:WST) Sees Large Volume Increase on Better-Than-Expected Earnings - MarketBeat
West Pharmaceutical Services, Inc.'s (NYSE:WST) Popularity With Investors Under Threat As Stock Sinks 35% - Simply Wall St
West Pharmaceutical Services (NYSE:WST) Rating Increased to Buy at Deutsche Bank Aktiengesellschaft - MarketBeat
StockNews.com Upgrades West Pharmaceutical Services (NYSE:WST) to Buy - MarketBeat
West Pharma’s Stock Plummets 38% as 2025 Outlook Disappoints Investors - PUNE.NEWS
West Pharmaceutical Unveils New Nested Format for Daikyo PLASCAP RUV Closures - MSN
Dynavax Technologies Corporation Enters into an Agreement with West Pharmaceutical Services, Inc - Marketscreener.com
Sector Update: Health Care Stocks Decline Late Afternoon -February 14, 2025 at 03:59 pm EST - Marketscreener.com
West Pharmaceutical Services (NYSE:WST) Issues Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
Sector Update: Health Care Stocks Retreat Friday Afternoon -February 14, 2025 at 01:59 pm EST - Marketscreener.com
Why West Pharmaceutical Shares Are on the Rise Again - TipRanks
West Earnings: Valuation Lowered After Guidance Disappoints and Recovery Trajectory Delayed - Morningstar
West Pharmaceutical Servs's Options Frenzy: What You Need to Know - Benzinga
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar
Stock Market Surge: Tesla, Nvidia, and Other Mega-Cap Movers Drive Market Dynamics While West Pharma and Trade Desk Struggle – market - HPBL
KeyBanc Adjusts Price Target on West Pharmaceutical Services to $325 From $470 - Marketscreener.com
West Pharmaceutical Services (NYSE:WST) Reaches New 52-Week LowWhat's Next? - MarketBeat
West Pharmaceutical Services Stock Touches 'Attractive Entry Point,' Deutsche Bank Says - Marketscreener.com
West Pharma stock upgraded at Deutsche Bank (WST:NYSE) - Seeking Alpha
West Pharmaceutical forecasts 2025 results below expectations, shares drop - MSN
West Pharmaceutical Services (NYSE:WST) Updates FY 2025 Earnings Guidance - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript - Insider Monkey
West Pharmaceutical price target lowered to $325 from $470 at KeyBanc - TipRanks
West Pharmaceutical Services Inc (WST) 財務データ
収益
当期純利益
現金流量
EPS
0.26%
3.85%
大文字化:
|
ボリューム (24 時間):